logo
episode-header-image
Jul 2024
24m 34s

Episode 108: Colorectal Cancer Series, P...

Rouleaux University Medical Center
About this episode

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.

Contents:

- What is the role of immunotherapy?

- What is the role of BRAF inhibition?

- Can we use HER2 targeted therapies?

- What is the role of more intensive chemotherapy regiments for patients?

**Have some time and want to make some extra money? Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Up next
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we highly recommend listening to part 3 of our follicular lymphoma series. You may al ... Show More
36m 11s
Sep 10
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 ... Show More
29m 51s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. Episode contents:- What is the front-line approach to management for locali ... Show More
30m 11s
Recommended Episodes
Jul 2021
1: It starts with Staph
In the first episode of the ID:IOTS podcast Callum and Jame talk for longer than intended about everyone's favourite Gram positive coccus, Staphylococcus aureus.Support the Show.Questions, comments, suggestions to idiotspodcasting@gmail.com or on X/Threads @IDiots_pod Prep n ... Show More
37m 40s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal improvem ... Show More
24m 4s
Feb 2025
3290: Coros Pace 3 vs. Apple Watch Review, Dostarlimab and Endometrial & Colorectal Cancer Research (FR)
Welcome back to today’s Friday Review where I’ll be breaking down the best of the week!     I’ll be sharing specifics on these topics:     Weekly Podcast Recap Coros Pace 3 vs. Apple Watch (product review) Dostarlimab and Endometrial & Colorectal Cancer (research)   For all the d ... Show More
19m 46s
Apr 2023
#58 Rheumatoid arthritis (part 1)
Consultant Rheumatologist and co-host of the Medical Take podcast, Dr Arrianne Laws, joins Sam on the podcast this week to discuss another PACES classic of rheumatoid arthritis. Listen to more of Arrianne on the Medical Take Podcast! Click here! ^_^ SUPPORT THE SHOW ^_^ > > Acces ... Show More
43m 50s
Sep 4
Colorectal Cancer
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We start by brea ... Show More
37m 25s
Feb 2024
129 - Ozempic, Fiber, Strength Training - Oh My!
We're coming in hot! This week we are discussing some recent research and case studies involving Ozempic and muscle loss - there has been some new research coming out and it really shows the importance of lifestyle change in conjunction with weight loss drugs! We also discuss ... Show More
50 m
Mar 2025
103. Fungal infections overview and series intro
My my! Mycology?Join Callum and special co-host Alyssa for this, the first in the all new ID:IOTS Mycology Mega-series. Here we cover:What the British Society of Medical Mycology is and what they do Why we're doing this series on fungi  The Global and UK Burden of fungal dis ... Show More
31m 4s
Mar 2025
Lymphoma
Ninja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Lymphoma, breaking down its pathogenesis, clinical presentation, and the latest advancements in treatment. We explore the key differences between Hodgkin and Non-Hodgkin Lymphoma, ... Show More
34m 14s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and the ... Show More
24m 31s
Sep 3
The Dr. Ardis Show | True or False: Levothyroxine Increases Risk of Developing Cancers? | Episode 08.27.2025
In this week’s episode of The Dr. Ardis Show, Dr. Ardis sounds the alarm on one of the most widely prescribed thyroid medications in America - levothyroxine. Used by over 22 million Americans to treat hypothyroidism, new research suggests this FDA-approved drug may increase the r ... Show More
40m 50s